Clinical Laboratory Services Market, 5th Edition

Table of Contents

Chapter One: Executive Summary

Industry at a Glance

Scope and Methodology

Global Market Overview

• • Table 1-1: Global Clinical Laboratory Market Analysis, 2010-2024 (in millions of dollars at the manufacturerís level)

• Figure 1-1: Global Clinical Laboratory Market Analysis: 2010-2024
• Market Conclusions

Key Issues and Trends Affecting the Market
Leading Market Participants

Chapter Two: Industry Overview
Clinical Laboratory Description
Number of Laboratory Health Workers by Country

• • Figure 2-1: Laboratory Health Workers by Country, 2010-2018 Average

The Largest Clinical Laboratory Market: The United States

• Structure and Regulation in the U.S.
  • Table 2-1: Selected CLIA Waived Laboratory Tests
• • Table 2-2: Provider-Performed Microscopy Procedures
• • Figure 2-2: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), July 2019
• • Table 2-3: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), July 2019
• • Figure 2-3: Laboratory Certificate Trends by Application Type, July 2010- July 2019
• • Table 2-4: CLIA Exempt States, Number of Laboratories, July 2019

Laboratory Developed Test Regulations

• Directive 98/79/EC
• Health Canada Changes and Forecasted Action

Payers and Reimbursement

• Laboratory Service Payer Types
  • Table 2-5: U.S. Clinical Laboratory Revenues by Client and Payer Type (%), 2019
• • Figure 2-4: Clinical Laboratory Revenues by Client and Payer Type, 2019 Estimates
• Trends in Medicare Reimbursement
  • Figure 2-5: Medicare Reimbursement Trends, Average Reimbursement for Clinical Laboratory Services, 2009 through 2020
• Health Care Reform
• Protecting Access to Medicare Act (PAMA) of 2014
  • Table 2-6: Clinical Diagnostic Laboratory Test Rates, 2020-2023
• Advanced Laboratory Tests (ADLT)
  • Table 2-7: List of Approved ADLTs, 2019
• Bundled Insurance Payments for ESRD Patients
  • Table 2-8: Laboratory Tests Subject to ESRD Consolidated Billing (CY 2019)
• • Table 2-9: Comparison between New Bundled and Composite Medicare Reimbursement Program (1983-2010 and 2011+)
• Commercial Insurance Providers
  • Table 2-10: National Commercial Insurance Provider List, 2018
• • Figure 2-6: National Commercial Insurance Providers by Membership and Total Revenues, 2018

Transparency in Pricing

• Figure 2-7: Revenue and Test Volume Trends, Quest Diagnostics

Direct-to-Consumer Testing

• Table 2-11: Select DTC Tests and Prices by Laboratory Service Provider (Quest Direct and Pixel LabCorp) 2019 (in US $)
• DTC in Genetic Testing

Expanding Cancer Test Utilization and Technologies

• LabCorp and QIAGEN Launch new Companion Diagnostic for Metastatic Breast Cancer Therapy
• Foundation Medicine signs $111M contract with Department of Veterans Affairs
• Quest Diagnostics Attention to Oncology

The Role of Information Technology

• Table 2-12: Selected Laboratory Information Management System Providers, 2018 Vendor List

Industry Drivers

• Global Demographics
  • Table 2-13: The Global Population, 1980-2050
• • Figure 2-8: The Global Population, 1980-2050 (in millions)
• • Table 2-14: World Population by Major Geographic Region, 2010 ñ 2050 (Asia Pacific, Europe, North America, Latin America, Rest of World, World)
• • Figure 2-9: World Population by Major Geographic Region, 2010ñ2050 (Asia Pacific, Europe, North America, Latin America, Rest of World)
• • Table 2-15: Global Population Trends Age 65+, 2000-2050
• • Figure 2-10: Global Population Trends Age 65+, 2000-2050 (Millions)
• Chronic Diseases and Conditions
  • Figure 2-11: Global Prevalence of Disease, 2000, 2015 and Projected 2030 (Hypertension, Diabetes Mellitus, Depression, Asthma, Coronary Heart Disease / Ischemic Heart Disease, COPD, Epilepsy, Alzheimer’s Disease, HIV/AIDS, Stroke Survivors, Cancer, Tuberculosis, Parkinson’s Disease, ESRD)
• • Figure 2-12: Global Causes of Death, 2000, 2010 and 2016 (All Other Causes, Ischemic Heart Disease, Cancers [all types], Stroke, Influenza/Pneumonia, COPD, Alzheimer disease / dementias, Diabetes Mellitus, Road Injuries, Diarrheal Diseases, Tuberculosis, Cirrhosis of the Liver, Kidney disease, HIV/AIDS, Hypertensive Heart Disease)
• • Figure 2-13: Change in Mortality Over 2000-2016 Period
• Surgical Procedure Volumes
  • Table 2-16: Global Surgical Procedure Volume Forecast by Region, 2015-2030* (procedures in thousands)
• Economic Performance
  • Table 2-17: U.S. Centers for Medicare & Medicaid Services, U.S. Department of Health and Human Services, National Health Expenditure Projects 2018-2027: Fact Sheet
• • Figure 2-14: Global Health Spending as a Percentage of GDP, by Country, 2018 estimates (%)(Australia, Canada, Chile, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Mexico, Netherlands, New Zealand, Poland, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States)

Chapter Three: Testing Services by Specialty
Test and Services Overview

• • Table 3-1: Global Clinical Laboratory Market Analysis by Test Segment (Clinical Chemistry: Routine & Essential, Immunology & Microbiology, Cytology & Histology, Genetic, Toxicology), 2010-2024 (in millions of dollars at the manufacturersí level)
    • Figure 3-1: Global Clinical Laboratory Market Analysis: Service Revenue Trend, 2010-2024
  • • Figure 3-2: Global Clinical Laboratory Market Analysis: Segment Growth Forecast, CAGR 2019-2024 (Clinical Chemistry – Routine & Essential Testing, Immunology & Microbiology Testing, Cytology & Histology Testing, Genetic Testing, Toxicology Testing)
  • • Figure 3-3: Global Clinical Laboratory Market Analysis by Testing Service, Distribution of Revenues 2019 (%)(Clinical Chemistry – Routine & Essential Testing, Immunology & Microbiology Testing, Cytology & Histology Testing, Genetic Testing, Toxicology Testing)

Clinical Chemistry – Routine and Essential Testing

• • Figure 3-4: Global Clinical Laboratory Market Analysis: Clinical Chemistry: Routine & Essential Testing Service Market Trend, 2010-2024
    • Table 3-2: Market Overview – Routine and Essential Testing, 2019 (Clinical Chemistry, Hematology, Coagulation, Endocrinology, Others, Total)
  • Routine Clinical Chemistry
  • Cholesterol Level Testing
    • Table 3-3: High Cholesterol Risk Categories
  • • Table 3-4: Raised or At-Risk Total Cholesterol (> = 190 mg/dL) age standardized estimates, 2008 data (Iceland, Germany, Denmark, United Kingdom, Ireland, Italy, France, Netherlands, Switzerland, United Arab Emirates, Singapore, Japan, Poland, Thailand, Australia, United States, Israel, Canada, Mexico, Russian Federation, Argentina, Brazil, Philippines, Republic of Korea, Turkey, Saudi Arabia, Venezuela, China, India)
  • Urinalysis
    • Table 3-5: Normal Reference Levels in a Medical Urinalysis
  • Hematology
    • Table 3-6: Laboratory Reference Parameters for CBC
  • Coagulation
  • Endocrinology
    • Table 3-7: HCG Levels in Pregnant Women by Days Past Ovulation

Immunology and Microbiology

• • Figure 3-5: Global Clinical Laboratory Market Analysis: Immunology & Microbiology Testing Service Market Trend, 2010-2024
    • Table 3-8: Market Overview – Immunology & Microbiology Testing, 2019 (Infectious disease, Immunology, Total)
  • Allergy and Food Intolerance
  • Tumor Markers
  • Cardiac Markers
  • HIV Testing
    • Table 3-9: Number of Reported HIV Testing and Counseling Services by Country, 2014 (India, Ethiopia, Uganda, Kenya, Nigeria, Mozambique, South Africa, Rwanda, United Republic of Tanzania, Zambia, Mexico, Kazakhstan, Malawi, Viet Nam, CÙte d’Ivoire, Democratic Republic of the Congo, Zimbabwe, Malaysia, Thailand, Haiti, Peru, Belarus, Indonesia, Burundi, Cuba)
  • • Figure 3-6: Number of HIV Testing/Counseling Facilities per 100,000 Adult Populations and HIV Positive Population per 1,000 by Select Country (2017) (Argentina, Bangladesh, Bolivia, Botswana, Brazil, Bulgaria, Chile, Egypt, India, Indonesia, Malaysia, Nicaragua, Peru, South Africa, Zambia, Zimbabwe)

Cytology and Histology Testing

• • Figure 3-7: Global Clinical Laboratory Market Analysis: Cytology & Histology Testing Service Market Trend, 2010-2024
    • Table 3-10: Market Overview – Cytology & Histology Testing, 2019 (HPV Testing [Routine/DNA], Tumor Pathology, Total)
  • Pap Test
    • Figure 3-8: Percent of Females Aged 20-69 Screened for Cervical Cancer (all screening methods), by Select Country 2016/2017 Estimates (Canada, France, Germany, Hungary, Israel, Italy, Japan, South Korea, Netherlands, Poland, Spain, Switzerland, Turkey, United Kingdom, United States)
  • • Table 3-11: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2017 (Afghanistan, Argentina, Australia, Bangladesh, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, France, Germany, Hungary, India, Indonesia, Iran [Islamic Republic of], Iraq, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Republic of Korea, Romania, Russian Federation, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, Ukraine, United Arab Emirates, United Kingdom of Great Britain and Northern Ireland, United States of America, Venezuela [Bolivarian Republic of], Viet Nam, Afghanistan)

Genetic Testing

• • Figure 3-9: Global Clinical Laboratory Market Analysis: Genetic Testing Service Market Trend, 2010-2024
    • Table 3-12: Market Overview – Genetic Testing, 2019 (Prenatal/Newborn Screening, Other Genetic Screening, Total)

Toxicology Testing

• • Figure 3-10: Global Clinical Laboratory Market Analysis: Toxicology Testing Service Market Trend, 2010-2024
    • Table 3-13: Substance Detection Periods by Test Method (Urine, Blood, Hair)
  • • Table 3-14: Screening and Brief Interventions for Substance Abuse by Select Country, 2014 data (Argentina, Australia, Austria, Bangladesh, Brazil, Chile, China, Egypt, Finland, Iraq, Ireland, Israel, Italy, Malaysia, Mexico, New Zealand, Peru, Philippines, Republic of Korea, Romania, Russian Federation, Saudi Arabia, Spain, Sweden, Turkey, United Arab Emirates, United Kingdom, United States of America, Viet Nam)

Chapter Four: Global Clinical Laboratory Market by Provider Group
Clinical Laboratory Market: Provider Overview

• • Table 4-1: Global Clinical Laboratory Market Analysis by Provider Segment (Hospitals, Physician Offices/Outpatient Clinics, Independent), 2010-2024 (in millions of dollars at the manufacturersí level)
    • Figure 4-1: Global Clinical Laboratory Market Analysis: Provider Segment Growth Forecast, CAGR 2019-2024 (Hospital and Acute Laboratory Service Providers, Physician and Outpatient Clinic Laboratory Service Providers, Independent Laboratory Service Providers)
  • • Figure 4-2: Global Clinical Laboratory Market Analysis by Provider Group, Distribution of Revenues 2019 (%)(Hospital and Acute Laboratory Service Providers, Physician and Outpatient Clinic Laboratory Service Providers, Independent Laboratory Service Providers)

Hospitals and Acute Care Providers

• • Table 4-2: Global Clinical Laboratory Market Analysis: Hospital and Acute Care Laboratory Testing Market 2019 and 2024 (U.S./International Estimates)
    • Table 4-3: Hospital Density per 100,000 Population by Country, 2013 (Afghanistan; Brazil; Canada; China; France; Finland; Germany; Iceland; Indonesia; Iraq; Israel; Italy; Japan; Korea, Republic of; Malaysia; Mexico; Netherlands; Pakistan; Philippines; Poland; Saudi Arabia; Singapore; South Africa; Thailand; Turkey; United Kingdom; United States)
  • • Figure 4-3: Hospitals per 100,000 Population by Country, 2013 (Afghanistan; Brazil; Canada; China; France; Finland; Germany; Iceland; Indonesia; Iraq; Israel; Italy; Japan; Korea, Republic of; Malaysia; Mexico; Netherlands; Pakistan; Philippines; Poland; Saudi Arabia; Singapore; South Africa; Thailand; Turkey; United Kingdom; United States)

Physicians and Outpatient Care Providers

• • Table 4-4: Global Clinical Laboratory Market Analysis: Physician and Outpatient Care Laboratory Testing Market 2019 and 2024 (U.S./International Estimates)
  • Physician Offices
    • Table 4-5: Medical Doctors per 1,000 Population by Country, 2017/2018 (Afghanistan; Argentina; Australia; Brazil; Canada; China; France; Germany; India; Ireland; Israel; Italy; Japan; Korea, Republic of; Mexico; Netherlands; Poland; Romania; Russian Federation; Saudi Arabia; Singapore; South Africa; Spain; Sweden; Switzerland; Turkey; United Kingdom; United States; Vietnam)
  • • Figure 4-4: Medical Doctors per 1,000 Population by Country, 2017/2018 (Afghanistan; Argentina; Australia; Brazil; Canada; China; France; Germany; India; Ireland; Israel; Italy; Japan; Korea, Republic of; Mexico; Netherlands; Poland; Romania; Russian Federation; Saudi Arabia; Singapore; South Africa; Spain; Sweden; Switzerland; Turkey; United Kingdom; United States; Vietnam)
  • Global Nursing Establishments and Assisted Living Facilities
    • Table 4-6: Estimated Nursing Service Establishments and Care Centers by Country, 2017 (Australia, Canada, China, France, Germany, Italy, Japan, Netherlands, Sweden, Switzerland, United Kingdom, United States)
  • • Figure 4-5: Estimated Nursing Service Establishments and Care Centers by Country, 2017 (Australia, Canada, China, France, Germany, Italy, Japan, Netherlands, Sweden, Switzerland, United Kingdom, United States)
  • Global Dialysis Clinics

Independent Laboratory Providers

• • Table 4-7: Global Clinical Laboratory Market Analysis: Independent Laboratory Testing Market 2019 and 2024 (U.S./International Estimates)

Chapter Five: North America Market
Overview

• • Table 5-1: North America Market Value by Country, 2019 (in millions of dollars at the manufacturersí level) (Canada, United States, Rest of Northern America)

United States

• • Table 5-2: The United States Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)
  • U.S. Market Analysis by Test Type
    • Table 5-3: The United States Clinical Laboratory Service Market by Testing Services, Estimates and Forecast 2019 and 2024 ($millions) (Essential & Routine, Immunology & Microbiology, Cytology & Pathology, Genetic, Toxicology)
  • • Figure 5-1: U.S. Clinical Laboratory Market Analysis: Testing Service Revenues by Type, 2019 (%) (Essential & Routine, Immunology & Microbiology, Cytology & Pathology, Genetic, Toxicology)
  • U.S. Market Analysis by Laboratory Provider Type
    • Table 5-4: The United States Clinical Laboratory Service Market by Laboratory Type, Estimates and Forecast 2019 and 2024 ($millions) (Hospital-based and Acute Care Laboratory, Physician-based and Outpatient Laboratory, Independent Laboratory)
  • • Figure 5-2: U.S. Clinical Laboratory Market Share by Laboratory Type, 2019 (%) (Hospital-based, Independent, Physician-based)
  • U.S. Clinical Laboratory Industry Structure
    • Figure 5-3: Growth in Clinical Laboratories, 1997-2019
  • • Figure 5-4: U.S. CLIA Clinical Laboratory Registration by Primary Laboratory Type: July 2019 (Physician Office, SNF/Nursing Facility, Home Health Agency, Pharmacy, Hospital, ESRD Clinic, Community Clinic, Independent, Ambulatory Surgery Center, Assisted Living Facility, Others)
  • • Table 5-5: CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined) July 2019 (Ambulance, Ambulatory Surgery Center, Ancillary Test Site, Assisted Living Facility, Blood Bank, Community Clinic, Comprehensive Outpatient Rehab, End Stage Renal Disease Dialysis, Federally Qualified Health Center, Health Fair, Health Maintenance Organization, Home Health Agency, Hospice, Hospital, Independent, Industrial, Insurance, Intermediate Care Facility for Mentally Retarded, Mobile Laboratory, Pharmacy, Physician Office, Other Practitioner, Prison, Public Health Laboratory, Rural Health Clinic, School/Student Health Service, Skilled Nursing/Nursing Facility, Tissue Bank/Repository, Other, Total)
  • • Figure 5-5: Growth Trends in CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined) June 2011 and July 2019 (Ambulance, Ambulatory Surgery Center, Ancillary Test Site, Assisted Living Facility, Blood Banks, Community Clinic, Comprehensive Outpatient Rehab, End Stage Renal Disease Dialysis, Federally Qualified Health Center, Health Fair, Health Maintenance Organization, Home Health Agency, Hospice, Hospital, Independent, Industrial, Insurance, Intermediate Care Facility for Mentally Retarded, Mobile Laboratory, Pharmacy, Physician Office, Other Practitioner, Prison, Public Health Laboratory, Rural Health Clinic, School/Student Health Service, Skilled Nursing, Tissue Bank/Repositories, Other)
  • • Figure 5-6: Change in CLIA Registered Laboratories by Type of Facility, Highest and Lowest Growth Segments, % Change, Compounded Annually 2011-2019
  • Independent Clinical Laboratories
    • Table 5-6: Leading U.S. Independent Laboratory Groups, as of July 2019
  • • Figure 5-7: Leading U.S. Independent Laboratory Groups, Distribution of Centers, as of July 2019 (%)
  • • Figure 5-8: Growth in U.S. Independent Laboratory Facilities, June 2011 through July 2019
  • Hospital-based Laboratories
    • Figure 5-9: Number of Hospitals in the U.S., 1975-2018
  • • Table 5-7: U.S. Hospital Types
  • • Table 5-8: AHA Statistics – U.S. Registered Hospitals by Type, 2010 through 2017 (Community Hospitals, Federal Government Hospitals, Non-federal Psychiatric Hospitals, Non-federal Long-term Care Hospitals, Institutional Hospitals [includes prison hospitals, college infirmaries, etc.])
  • • Table 5-9: AHA Statistics for U.S. Hospitals, 2012-2017
  • • Figure 5-10: U.S. Hospital Length of Stay, Average by Broad Age Group, 2016 (under 1 year, 1-17 years, 18-44 years, 45-64 years, 65-84 years, 85+ years)
  • • Figure 5-11: Growth in U.S. Hospital Laboratory Locations, June 2011 through July 2019
  • Physician-office and Clinic Laboratories
    • Figure 5-12: Number of Physician Offices, United States, 2000-2017, Estimated 2018
  • • Figure 5-13: Growth in U.S. Physician Office Laboratory Locations, June 2011 through July 2019
  • Nursing Facility and Home Health
    • Figure 5-14: Number of Nursing Homes (United States), 2000-2017, Estimated 2018
  • • Figure 5-15: Growth in U.S. Nursing Facility/Home Health Laboratory Locations, June 2011 through July 2019
  • Pharmacy-based Laboratories
    • Figure 5-16: Growth in U.S. Pharmacy-Based Laboratories, mid-2011 through July 2019
  • Dialysis Clinics
    • Figure 5-17: Growth in U.S. Dialysis Clinic-based Laboratories, mid-2011 through July 2019

Canada

• • Table 5-10: Canada Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)

Chapter Six: EMEA Market
Overview

• • Table 6-1: EMEA Market Value by Country, 2019 (in millions of dollars at the manufacturersí level) (Germany, France, Italy, Spain, United Kingdom, Switzerland, Rest of EMEA, Total)
    • Figure 6-1: EMEA Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2019-2024 (Germany, France, Italy, Spain, United Kingdom, Switzerland, Rest of EMEA)

Germany

• • Table 6-2: Germany Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)
    • Figure 6-2: Leading Laboratory Service Suppliers by Estimated Distribution of Revenues, Germany, 2019 (%)

France

• • Table 6-3: France Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)

Italy

• • Table 6-4: Italy Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)

Spain

• • Table 6-5: Spain Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)

United Kingdom

• • Table 6-6: United Kingdom Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)

Switzerland

• • Table 6-7: Switzerland Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)

Rest of EMEA

• Middle East
• Turkey

Chapter Seven: Asia Pacific Market
Overview

• • Table 7-1: Asia Pacific Clinical Laboratory Service Market Value by Country, 2019 (in millions of dollars at the manufacturersí level) (China; Japan; India; Korea, S.; Australia; Rest of Asia Pacific; Total)
    • Figure 7-1: Asia Pacific Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2019-2024 (%) (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)

Japan

• • Table 7-2: Japan Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)
  • Japan Clinical Laboratory Industry Structure
    • Figure 7-2: Japan Clinical Laboratory Industry by Type, 2019 (%) (Hospital, Independent/Reference, University)
  • • Figure 7-3: Japan Clinical Laboratory Industry by Test Classification, 2019 (%) (Basic [essential/routine], Non-Basic, Pathology, Other Test Services)
  • • Figure 7-4: Japan Clinical Laboratory Industry, Number of Laboratories by Prefecture, 2019 (%)

China

• • Table 7-3: China Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)
  • China Clinical Laboratory Industry Structure
    • Figure 7-5: China Clinical Laboratory Industry by Type, 2019 (%) (Hospital, Independent/Reference, University)

India

• • Table 7-4: India Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)

South Korea

• • Table 7-5: South Korea Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)

Australia

• • Table 7-6: Australia Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)

Rest of Asia Pacific

• Singapore
• Indonesia
• Philippines
• Taiwan

Chapter Eight: Latin America Market
Overview

• • Table 8-1: Latin America Market Value by Country, 2019 (in millions of dollars at the manufacturersí level) (Brazil, Mexico, Rest of Latin America, Total)
    • Figure 8-1: Latin America Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2019-2024 (Brazil, Mexico, Rest of Latin America)

Brazil

• • Table 8-2: Brazil Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)

Mexico

• • Table 8-3: Mexico Clinical Laboratory Service Market, Estimates and Forecast 2019 and 2024 ($millions)

Rest of Latin America

• Argentina
• Chile
  • Table 8-4: Estimated Clinical Labs in Chile (Average Tests/Year, Number of Labs, Private Sector, Public Sector)
• Colombia
  • Table 8-5: Classification of Laboratories by Test Complexity
• Peru
• Venezuela

Chapter Nine: Leading Market Participants
Global Competitor Summary

• • Figure 9-1: Leading Market Participants, Global Service Revenues, 2018 and Estimated 2019 ($millions)

U.S. Competitive Analysis

• • Table 9-1: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2019
    • Figure 9-2: Estimated U.S. Laboratory Services, Market Share of Leading Clinical Laboratory Providers, 2019 (%)

Abbott Laboratories

• Company Overview
  • Table 9-2: Abbott Laboratories Corporate Details
• Performance Review
  • Figure 9-3: Abbott Laboratories Revenue Summary, 2010-2019 ($millions)
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

ACM Global Laboratories, Inc.

• Company Overview
  • Table 9-3: ACM Global Laboratories Corporate Details
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

ARUP Laboratories

• Company Overview
  • Table 9-4: ARUP Laboratories Corporate Details
• Performance Review
  • Figure 9-4: ARUP Laboratories Revenue Summary, 2010-2019 ($millions)
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

BioReference Laboratories – An OPKO Health Subsidiary

• Company Overview
  • Table 9-5: BioReference Laboratories Corporate Details
• Key Acquisitions, Alliances, and Partnerships
• Performance Review
  • Figure 9-5: BioReference Laboratories Revenue Summary, 2010-2019 ($millions)
• Products and Services

DaVita, Inc.

• Company Overview
  • Table 9-6: DaVita Healthcare Corporate Details
• Performance Review
  • Figure 9-6: DaVita Revenue Summary, 2010-2019 ($millions)
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

Exact Sciences Corp.

• Company Overview
  • Table 9-7: Exact Sciences Corporate Details
• Performance Review
  • Figure 9-7: Exact Sciences Revenue Summary, 2010-2019 ($millions)
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

Eurofins Scientific SE

• Company Overview
  • Table 9-8: Eurofins Scientific Corporate Details
• Performance Review
  • Figure 9-8: Eurofins Scientific Revenue Summary, 2010-2019 ($millions)
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

Laboratory Corporation of America (LabCorp)

• Company Overview
  • Table 9-9: Laboratory Corporation of America Corporate Details
• Performance Review
  • Figure 9-9: Laboratory Corporation of America Revenue Summary, 2010-2019 ($millions)
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

Miraca Holdings, Inc.

• Company Overview
  • Table 9-10: Miraca Corporate Details
• Performance Review
  • Figure 9-10: Miraca Revenue Summary, 2010-2019 ($millions)
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

Myriad Genetics, Inc.

• Company Overview
  • Table 9-11: Myriad Genetics Corporate Details
• Performance Review
  • Figure 9-11: Myriad Genetics Revenue Summary, FY 2010-2019 ($millions)
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

NeoGenomics, Inc.

• Company Overview
  • Table 9-12: NeoGenomics Inc. Corporate Details
• Performance Review
  • Figure 9-12: NeoGenomics Revenue Summary, 2010-2019 ($millions)
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

Quest Diagnostics, Inc.

• Company Overview
  • Table 9-13: Quest Diagnostics Corporate Details
• Performance Review
  • Figure 9-13: Quest Diagnostics Revenue Summary, 2010-2019 ($millions)
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

Siemens Healthineers

• Company Overview
  • Table 9-14: Siemens Healthineers Corporate Details
• Performance Review
  • Figure 9-14: Siemens Healthineers’ Revenue Summary, 2010-2019 ($millions)
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

Sonic Healthcare Limited

• Company Overview
  • Table 9-15: Sonic Healthcare Corporate Details
• Performance Review
  • Figure 9-15: Sonic Healthcare Revenue Summary, 2010-2019 ($millions)
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

Spectra Laboratories: A Fresenius Company

• Company Overview
  • Table 9-16: Spectra Laboratories Corporate Details
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

SYNLAB International GmbH (SYNLAB Bondco PLC)

• Company Overview
  • Table 9-17: SYNLAB Corporate Details
• Performance Review
  • Figure 9-16: SYNLAB Revenue Summary, 2016-2019 ($millions)
• Key Acquisitions, Alliances, and Partnerships
• Products and Services

Chapter Ten: Market Trends and Summary
Global Market Overview

• • Table 10-1: Global Clinical Laboratory Market Analysis, 2010-2024 (in millions of dollars at the manufacturerís level)
    • Figure 10-1: Global Clinical Laboratory Market Analysis: 2010-2024

Regional Overview

• • Table 10-2: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2019 (Northern America; Europe, Middle East, Africa; Asia Pacific; Latin America; Total)
    • Figure 10-2: Global Clinical Laboratory Market Analysis, Revenues by Region, 2019 (%) (Northern America, EMEA, Asia Pacific, Latin America)
  • • Figure 10-3: Global Clinical Laboratory Market Analysis: Regional Growth Forecast, CAGR 2019-2024 (Northern America, EMEA, Asia Pacific, Latin America)

Trends

• Population Growth
• Aging Populations
• Increasing Disease Burden
• Economic Growth in Developing Regions
• Stabilizing Economies in Developed Regions
• Pricing Pressures
• Focusing on Efficient Health Systems
• Overall Growth in Demand for Health Care Services